Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study

AIMS: Nonvitamin K antagonist oral anticoagulants (NOACs) are now available for the prevention of stroke in patients with atrial fibrillation (AF) as an alternative to vitamin K antagonists (VKA) and aspirin. The comparative effectiveness and safety in daily practice of these different drug classes...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Clin Pharmacol
Autori principali: Gieling, Emilie M., van den Ham, Hendrika A., van Onzenoort, Hein, Bos, Jacqueline, Kramers, Cornelis, de Boer, Anthonius, de Vries, Frank, Burden, Andrea M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Pharmacoepidemiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510083/
https://ncbi.nlm.nih.gov/pubmed/28205318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13265
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi